Clinical Trial Update: Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Healthy Vietnamese Women According to a 0, 1, 6 Month Schedule [NA]

View source ↗

Summary

This document reports a safety study of GlaxoSmithKline's human papillomavirus (HPV) vaccine in healthy Vietnamese women using a 0, 1, 6 month schedule; the sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection

Drugs mentioned

• Cervarix (human papillomavirus vaccine, bivalent)

Snippet

Sponsor: National Institute for Control of Vaccine and Biologicals | Conditions: Human Papillomavirus (HPV) Vaccine | NA | Status: UNKNOWN